A carregar...
No need for H(2)-antagonists in premedication regimens for paclitaxel infusions: less is more
The theoretical basis for use of histamine 2 (H(2))-receptor inhibitors to prevent hypersensitivity reactions for paclitaxel infusions is weak. This Editorial discusses a clinical study showing that ranitidine is not indicated any more in this setting and puts this in the context of other valuable e...
Na minha lista:
| Publicado no: | Br J Cancer |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group UK
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7987749/ https://ncbi.nlm.nih.gov/pubmed/33762719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-021-01316-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|